Bisphosphonates Preserve Bone Mineral Density and Suppress Bone Turnover Markers in Early Menopausal Women: A Systematic Review and Meta‐Analysis of Randomized Trials

Bisphosphonates Preserve Bone Mineral Density and Suppress Bone Turnover Markers in Early Menopausal Women: A Systematic Review and Meta‐Analysis of Randomized Trials

ABSTRACT Most women do not qualify for pharmacologic osteoporosis treatment until more than a decade after menopause, by which time they will have lost up to 30% of their bone mass and may have already sustained fractures. Short or intermittent courses of bisphosphonate therapy, initiated around the...

Full description

Bibliographic Details
Main Authors: Aria Ahadzadeh Ardebili, Timothy Fu, Nicole Dunnewold, Fariba Aghajafari, Emma O. Billington
Format: Article
Language:English
Published: Wiley 2023-06-01
Series:JBMR Plus
Subjects:
ANTIRESORPTIVES
CLINICAL TRIALS
DXA
MENOPAUSE
OSTEOPOROSIS
Online Access:https://doi.org/10.1002/jbm4.10748

Similar Items

Similar Items